A rapid and efficient method for generating anti-variable region monoclonal antibodies using type-1 interferons as...

Area of Science:

• Immunology
• Biotechnology
• Pharmacology

Background:

• Therapeutic antibody assessment requires anti-variable region monoclonal antibodies (mAbs).
• Current methods for generating these mAbs are often time-consuming.
• Developing rapid and efficient mAb generation protocols is crucial for drug development.

Purpose of the Study:

• To develop a novel, rapid immunization method for generating anti-variable region mAbs.
• To utilize type 1 interferons (IFNs) and anti-CD40 mAb as immunomodulators for enhanced B cell responses.
• To generate mAb reagents for pharmacokinetic/pharmacodynamic (PK/PD) assessments of therapeutic antibodies.

Main Methods:

• A novel immunization protocol employing type 1 interferons (IFNs) as immunomodulators.
• Co-administration of an agonistic anti-CD40 mAb to stimulate B cell proliferation.
• Generation of anti-variable region mAbs without conventional protein-denaturing adjuvants.

Main Results:

• Achieved rapid and robust generation of anti-variable region mAbs.
• Obtained comparable or increased numbers of mAbs in a significantly shorter timeframe compared to conventional methods.
• Demonstrated the efficacy of IFNs and anti-CD40 mAb in driving potent humoral immune responses.

Conclusions:

• The novel IFN-based immunostimulatory approach enables faster generation of anti-variable region mAbs.
• This non-denaturing adjuvant method may favor the presentation of conformational epitopes.
• The protocol optimizes humoral responses for rapid generation of critical reagents for therapeutic mAb evaluation.